The Effects of Axitinib plus Tislelizumab in the Treatment of Advanced Renal Cell Carcinoma

Table 4

Treatment effects (n (%)).

Groups	n	CR	PR	SD	PD	ORR	DCR
Study group	22	0	13	5	4	59.1	81.8
Control group	27	0	11	7	9	40.7	66.7
X^2						6.771	5.963
value						0.009	0.015